<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63193</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-09</news:publication_date>
      <news:title>前糖尿病者、生活習慣改善やメトホルミンは多疾患併存リスクを軽減するか／JAMA</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63192</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-09</news:publication_date>
      <news:title>PSSA菌血症、ペニシリンG vs.抗ブドウ球菌ペニシリン／Lancet</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63191</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-09</news:publication_date>
      <news:title>再発・難治性B-NHLへのglofitamab、日本人第I相試験の結果</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63188</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-09</news:publication_date>
      <news:title>早期HR+/HER2-乳がん、術後アベマシクリブ初回用量漸増後24週時点での忍容性（TRADE）／ESMO Open</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63163</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-09</news:publication_date>
      <news:title>日本人統合失調症外来患者の再発率と関連する要因は～MUSASI研究</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63149</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-09</news:publication_date>
      <news:title>PPI中止後のGERD再燃、プロバイオティクスが抑制</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63180</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>EGFR-TKI後のNSCLC、ivonescimabがOSを改善／JAMA</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63178</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>タモキシフェン治療中の乳がん患者のホットフラッシュ、ベンラファキシンが有望（HOFLA-V試験）／日本乳癌学会</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63162</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>日本人片頭痛患者に対する3年間の抗CGRP抗体継続治療、その有用性は</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63157</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>移植適応のある未治療多発性骨髄腫へのテクリスタマブベースの導入療法～第II相試験（MajesTEC-5）</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63146</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>死亡リスクが低下する適切な筋トレ時間は？</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
</urlset>
